Plus: Deutsche Bank and Jeffrey Epstein’s ghost.
Fortune 500 Digest with Alyson Shontell
Saturday, October 11, 2025
Foreword
Alyson Shontell
Editor-in-Chief

For highly ambitious business leaders, there’s nothing more exhilarating than turning around a business that some thought couldn’t be saved.

Earlier this week, we highlighted two CEOs who have brought companies back from the brink.

One of them is Jamie Dimon protégé and Wells Fargo CEO Charlie Scharf. When Scharf took the helm of Wells in 2019, it was embroiled in a regulatory crackdown, and its brand had been severely damaged due to a widespread “fake accounts” scandal.

“I remember knowing what I was getting myself into, but it was much worse directionally than I thought,” Scharf told Fortune’s Shawn Tully. “The regulatory pressure was beyond anything I’ve experienced, and so was the political pressure.”

His first move was to create a physical plan of attack in the form of a 3,162-page document with 6,000 tasks. Progress on the extensive to-do list was tracked every Monday morning in a two-hour meeting where leaders either sank or swam.

Today, the work isn’t finished, but the company is much healthier. The central bank has lifted an asset cap that checked Wells’ growth, and under Scharf’s watch the stock has jumped from $52 to upwards of $80.

Meanwhile in retail, a wunderkind is minting a reputation as a turnaround guru. Damola Adamolekun had his first success at age 34, when he brought P.F. Chang’s through the pandemic and back to profitability. Now at 36, he’s attempting the “greatest comeback in the history of the restaurant industry” at the helm of Red Lobster. With a background in private equity, Adamolekun is moving fast, cutting bureaucracy, and making analytics-driven decisions to stabilize the business while also trying to improve employee morale.

For more on their turnaround playbooks, read the full features on Wells Fargo and Red Lobster.

Advertisement
Catch Up
Fortune 500 C-suite Power Moves
Verizon Communications (No. 30) appointed Dan Schulman as CEO. PepsiCo (No. 45) appointed Steve Schmitt as EVP and CFO, effective Nov. 10. TD Synnex (No. 73) appointed David Jordan as EVP and CFO. Campbell’s (No. 425) appointed Todd E. Cunfer as CFO, effective Oct. 20. Hertz Global Holdings (No. 440) promoted Mike Moore to COO. Vertiv Holdings (No. 471) announced that Stephen Liang is retiring from the role of CTO, effective Jan. 1, 2026.
And more in this week's Fortune 500 Power Moves.
Advertisement
Deals & Developments
  • Johnson & Johnson (No. 48) is in discussions to acquire Protagonist Therapeutics, per the Wall Street Journal. The companies are already working together to develop an oral treatment for plaque psoriasis and other immune-related diseases.
  • RTX (No. 54) agreed to sell Simmonds, a Vermont-based department of the Goodrich Corporation and manufacturer of fuel and aircraft systems, to TransDigm Group (No. 475) for approximately $765 million in cash. The acquisition will add to TransDigm Group’s existing portfolio of aircraft component offerings.
  • Bristol-Myers Squibb (No. 94) agreed to acquire RNA-based medicine developer Orbital Therapeutics for $1.5 billion in cash. In a press release announcing the deal, Bristol Myers Squibb’s EVP and Chief Research Officer Robert Plenge stated, “We are excited by the promise this holds for patients with autoimmune diseases who are waiting for better options.”
  • Fifth Third Bancorp (No. 320) agreed to acquire Comerica, a Texas-based financial services company, in a deal worth $10.9 billion. Once closed, the combined bank will hold approximately $288 billion in assets, making it the ninth-largest in the country.
  • As previously reported in Fortune 500 Digest: Lowe’s (No. 52) completed its acquisition of Foundation Building Materials (FBM), a North American distributor of interior building products (such as drywall and metal framing), for $8.8 billion. Also, Zimmer Biomet Holdings (No. 483) completed its acquisition of Monogram Technologies, an Austin-based orthopedic robotics company, for approximately $177 million. The acquisition will add to Zimmer Biomet’s existing medical robotics portfolio.
Overheard
“We’re finding all these micro demands and thinking how you build a brand around it.”
On earnings calls:
  • PepsiCo (No. 45) beat Wall Street estimates with $23.94 billion in quarterly revenue despite decreased demand, specifically in the company’s North American business. During a Q&A with analysts following the earnings announcement, CEO Ramon Laguarta said that the company is attacking its cost structures “with a very high sense of urgency,” but was optimistic about the company’s relaunch of its Lay’s, Tostitos, and Gatorade businesses, including ongoing initiatives to remove artificial dyes and flavors from its products. Read more: Inside PepsiCo’s beverage overhaul and Lay’s drastically rebrands after disturbing finding
  • Delta Air Lines (No. 70) beat Wall Street’s expectations with $15.2 billion in quarterly revenue. Performance was buoyed by a 9% increase in revenue from the airline’s higher-end seating offerings and an 8% jump in corporate travel revenue, while revenue from main-cabin fares fell 4%. Glen Hauenstein, president of the company, said during the earnings call that revenue from the airline’s premium offerings could surpass that of its main offerings next year, instead of in 2027 as previously estimated. Read more: Delta’s bet on wealthy Americans driving the economy is working
  • Constellation Brands (No. 418) reported quarterly net sales of $2.48 billion, exceeding analyst expectations but down from $2.92 billion a year earlier. During a Q&A session with analysts, CEO Bill Newlands noted that economic sentiment remains particularly weak among Hispanic consumers, a key demographic for the company’s Modelo and Corona beer brands. Net sales in the beer segment declined 7% for the quarter.
Earnings to watch next week include: Fastenal (No. 492) on Oct. 13; JPMorgan Chase (No. 11), Citigroup (No. 21), Goldman Sachs Group (No. 32), Wells Fargo (No. 33), Johnson & Johnson